(S)-10-(4-ethylpiperazin-1-yl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;(S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; UING 4-257;(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid(Levofloxacin Impurity);
N-Ethyl Levofloxacin is a fully characterized chemical compound used as a reference standard of API Levofloxacin. The standard offered is compliant with regulatory guidelines. N-Ethyl Levofloxacin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 106939-30-4
Related products
Levofloxacin EP Impurity D (Levofloxacin USP Related Compound F, Defluoro Levofloxacin)
M.F.
M.W. 343.38
CAT# AR-L13548
CAS# 117620-85-6
